pág. 453
New potent and selective human adenosine A[sub 3] receptor antagonists.
Pier G. Baraldi, Pier Andrea Borea
pág. 456
Fatal attractors: theoretical approaches to tumor differentiation.: theoretical approaches to tumor differentiation.
pág. 459
A new enzyme: insights into mechanisms of cell trafficking.: insights into mechanisms of cell trafficking.
Rebecca Lever
pág. 460
The true nature of pharmacogenomic associations?
Jeanette McCarthy
pág. 461
pág. 461
NK[sub 1] receptor antagonists--are they really without effect in the pain clinic?
Alyson J. Fox, Laszlo A. Urban
pág. 462
Reply: will changing the testing paradigms show that NK[sub 1] receptor anatgonists are analgesic in humans?: will changing the testing paradigms show that NK[sub 1] receptor anatgonists are analgesic in humans?
Ray Hill
pág. 465
Pharmacological chaperones: a new twist on receptor folding.: a new twist on receptor folding.
Ulla E. Petaja-Repo, Jean-Pierre Morello
pág. 466
PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer.: therapeutic role in diabetes, inflammation and cancer.
Julie C. Holder, Gregory J. Murphy
pág. 469
pág. 475
Pharmacotherapy for erectile dysfunction.
Trinity J. Bivalacqua, Hunter C. Champion
pág. 484
Src inhibitors: drugs for the treatment of osteoporosis, cancer or both?: drugs for the treatment of osteoporosis, cancer or both?
Mira Susa, Martin Missbach
pág. 489
Peripheral inducers of pain and hyperalgesia.
G.F. Gebhart
pág. 496
© 2001-2024 Fundación Dialnet · Todos los derechos reservados